Razoxane and Dexrazoxane - Two Multifunctional Agents
Experimental and Clinical Results
Book
Chapter
Razoxane (Rz) and dexrazoxane (DXRz) have several interesting modes of action. They block the cell division at the level of G2/M in the cell cycle, they have shown antiinvasive activity in preclinical experiments...
Chapter
In chapter 1, the preface is followed by a short overview on the historical development of two bisdioxopiperazine derivatives razoxane (ICRF-159) and dexrazoxane (ICRF-187) which are the subject of this book. ...
Chapter
In Chapter 2, preclinical and clinical data are given for razoxane, the older of the two drugs. The various modes of action of razoxane are briefly summarized, e.g. the block of the cell cycle in the G2/M phas...
Chapter
Dexrazoxane is highly effective in reducing anthracycline-induced cardiotoxicity and extravasation injury and is used clinically for these indications. Dexrazoxane has two potential pharmacological activities:...
Article
Article
Article
The concurrent administration of Metrazol (60 mg/kg, i.v.) to anaesthetized rats enhances the cerebral penetration of the anticancer agent razoxane. Such an enhancement leads to an increase in the therapeutic ...
Article
The effect of RA233 alone or in combination with radiation was investigated in vivo on the 5180 sarcoma, the B16 melanoma and the Lewis lung carcinoma.
Article
The effect of the platelet aggregation inhibitor RA233 alone or in combination with radiation was investigated on the spontaneously metastasizing B16 melanoma and on the Lewis lung carcinoma. The effect of thi...
Article
Metrazol enhanced the penetration of two proteins (125I human serum albumin and horseradish peroxidase), and the anticancer agent, razoxane, into the central nervous system of anaesthetized rats. Penetration was ...
Article
Razoxane (100 mg/kg) was administered to rats as a single IP dose. Plasma and CSF samples were obtained at intervals varying from 15 min to 24 h after dosing, and the razoxane was assayed by a new and simple h...